3Takahashi Y, Sugimoto K, Inui H, Fukusato T. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21:3777-3785 [PMID: 25852263 DOI: 10.3748/wjg.v21.i13.3777].
4Kucera O, Cervinkova Z. Experimental models of non-alcoholic fatty liver disease in rats. World J Gastroenterol 2014; 20:8364-8376 [PMID: 25024595 DOI: 10.3748/wjg.v20.i26.8364].
5Zhai Q, Bian XL, Yu B. Protective activity of Jiang- Zhi-Li-Gan against carbon tetrachloride-induced hepatic injury in mice. Pharm Biol 2010; 48:231-233 [PMID: 20645847 DOI: 10.3109/13880200903264442].
6Xiao J, Fai So K, Liong EC, Tipoe GL. Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. J Tradit Complement Med 2013; 3: 88-94 [PMID: 24716162 DOI: 10.4103/2225-4110.110 411].
7徐瑛,刘晏.张云鹏降脂理肝汤治疗脂肪肝临床观察.医药前沿2011;1:49.
8Day CP. Non-alcoholic fatty liver disease: a massive problem. Clin Med 2011; 11:176-178 [PMID: 21526706 DOI: 10.7861/clinmedicine.11-2-1761].
9Alam S, Gupta UD, Alam M, Kabir J, Chowdhury ZR, Alam AK. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. Indian J Gastroenterol 2014; 33:452-457 [PMID: 25023045 DOI: 10.1007/s12664-01443488-5].
10Li L, Li L, Chen L, Lin X, Xu Y, Ren J, Fu J, Qiu Y. Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats. J Pharmacol Sci 2015; 127:244-250 [PMID: 25837920 DOE 10.1016/ j.jphs.2014.12.001].
